Insulet Corporation Appoints Ashley Mc Evoy As President and Chief Executive Officer

Apr 28, 2025•3 months ago

Position

Chief Executive Officer

Company

Insulet

Ashley McEvoy

ActonMedicalBiotechnologyHealth Care

Description

Insulet Corporation has appointed Ashley McEvoy as President and Chief Executive Officer, succeeding Jim Hollingshead. This leadership change is effective immediately and aims to further Insulet's success in the MedTech market.

Company Information

Company

Insulet

Location

Acton, Massachusetts, United States

About

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Omnipod products are offered in 25 countries around the globe.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months